Bayer looks to find vaccine for Covid-19

<a rel="nofollow noopener noreferrer" data-snax-placeholder="Source" class="snax-figure-source" href="https://www.pharmaceutical-technology.com/wp-content/uploads/sites/10/2020/03/Bayer_2403.jpg" target="_blank">https://www.pharmaceutical-technology.com/wp-content/uploads/sites/10/2020/03/Bayer_2403.jpg</a>

Since chloroquine did not work as being a potential cure for the coronavirus (Covid-19), Bayer has taken another step to attempt to discover a vaccine.

On Tuesday, Bayer reached a drug development and licensing deal with Curadev.  Curadev is one of the largest research and development firms in India.

The reason for this deal is that Curadev could possibly be close to finding a vaccine.  Curadev utilizes some of the best medical cutting-edge technology in the world.  Curadev specializes in the Stimulator of Interferon Genes (STING) program.  The idea is to stimulate the immune system to fight back against any disease that cause inflammation within the cardiovascular region.